GTBP
GT Biopharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
No N-PORT holders.
No thesis.
GT Biopharma, Inc.
5.30
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Vanguard Capital ManagementVanguardindex-like | $184,436 | 17.94% | −16.70% | |
| 2 | Geode Capital ManagementGeodeindex-like | $130,648 | 12.71% | −9.40% | |
| 3 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $110,710 | 10.77% | 0.00% | |
| 4 | HRT FinancialHRT Financial | $52,000 | 5.06% | new | |
| 5 | Everhart Financial GroupEverhart Financial | $48,970 | 4.76% | new | |
| 6 | SRS Capital AdvisorsSRS Capital | $45,850 | 4.46% | 0.00% | |
| 7 | Opal Wealth AdvisorsOpal Wealth | $40,063 | 3.90% | new | |
| 8 | Northern TrustNorthern Trustindex-like | $36,953 | 3.59% | new | |
| 9 | 49 Wealth Management49 Wealth | $31,341 | 3.05% | new | |
| 10 | AlongsideAlongside | $31,341 | 3.05% | new | |
| 11 | Cetera Investment AdvisersCetera Investment | $27,392 | 2.66% | new | |
| 12 | SeaCrest Wealth ManagementSeaCrest Wealth | $24,534 | 2.39% | +0.20% | |
| 13 | Kitching PartnersKitching Partners | $24,485 | 2.38% | new | |
| 14 | PNC Financial Services GroupPNC Financial Services | $19,600 | 1.91% | new | |
| 15 | Advisor Group HoldingsAdvisor | $18,857 | 1.83% | +83.33% | |
| 16 | LPL FinancialLPL Financial | $17,815 | 1.73% | +19.74% | |
| 17 | Morgan StanleyMorgan Stanley | $11,054 | 1.08% | +35.99% | |
| 18 | Intl FcstoneIntl Fcstone | $11,000 | 1.07% | +57.62% | |
| 19 | Keel PointKeel Point | $10,170 | 0.99% | 0.00% | |
| 20 | Integrated Wealth ConceptsIntegrated Wealth Concepts | $9,797 | 0.95% | 0.00% | |
| 21 | CI Private WealthCI Private Wealth | $9,794 | 0.95% | new | |
| 22 | Private Wealth Management GroupPrivate Wealth | $9,794 | 0.95% | 0.00% | |
| 23 | Sagespring Wealth PartnersSagespring Wealth Partners | $9,794 | 0.95% | new | |
| 24 | Caitlin JohnCaitlin John | $8,080 | 0.79% | 0.00% | |
| 25 | Coston, McIsaac & PartnersCoston, McIsaac & Partners | $8,000 | 0.78% | 0.00% |
57 managers report $1.0M of GT Biopharma on form 13F for the quarter ended Jun 30 '26. 15 of them hold 80% of it; Vanguard is largest at 17.94%.
Expected move
No implied move.